148 / 220
N0 squamous cell carcinoma of the oral cavity and oropharynx.
Otolaryngol Head Neck Surg 2005;132(1):99
e
102
.
[18]
Sobin Leslie H, G MK, Wittekind Christian, editors. TNM clas- sification of malignant tumours. 7th ed. Wiley-Blackwell; 2009 .[19] T T. A package for survival analysis in R. 2015.
http://CRAN.R- project.org/package Z survival .[20]
Brown JS, Shaw RJ, Bekiroglu F, Rogers SN. Systematic review of the current evidence in the use of postoperative radiotherapy for oral squamous cell carcinoma. Br J Oral Maxillofac Surg 2012;50(6):481 e 9.
[21]
Ganly I, Goldstein D, Carlson DL, Patel SG, O’Sullivan B, Lee N, et al. Long-term regional control and survival in patients with “low-risk,” early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: the importance of tumor thickness. Cancer 2013;119(6):1168 e 76.
[22]
Woolgar JA, Rogers S, West CR, Errington RD, Brown JS, Vaughan ED. Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol 1999;35(3):257 e 65.
[23]
Valsecchi ME, Silbermins D, de Rosa N, Wong SL, Lyman GH. Lymphaticmapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol 2011;29(11):1479 e 87.
[24]
Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014;370(7):599 e 609.
[25]
Pesek S, Ashikaga T, Krag LE, Krag D. The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-anal- ysis. World J Surg 2012;36(9):2239 e 51.
[26]
Schiefke F, Akdemir M, Weber A, Akdemir D, Singer S, Frerich B. Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection. Head Neck 2009;31(4):503 e 12.
[27]
Murer K, Huber GF, Haile SR, Stoeckli SJ. Comparison of morbidity between sentinel node biopsy and elective neck dissec- tion for treatment of the n0 neck in patients with oral squamous cell carcinoma. Head Neck 2011;33(9):1260 e 4.
[28]
O’Connor R, Pezier T, Schilling C, McGurk M. The relative cost of sentinel lymph node biopsy in early oral cancer. J Cranio- maxillofac Surg 2013;41(8):721 e 7.
[29]
Broglie MA, Haerle SK, Huber GF, Haile SR, Stoeckli SJ. Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: impact on survival. Head Neck 2013;35(5):660 e 6.
[30]
Den Toom IJ, Heuveling DA, Flach GB, van Weert S, Karagozoglu KH, van Schie A, et al. Sentinel node biopsy for early-stage oral cavity cancer: the VU University Medical Center experience. Head Neck 2014 .[31]
Heuveling DA, van Weert S, Karagozoglu KH, de Bree R. Evaluation of the use of freehand SPECT for sentinel node bi- opsy in early stage oral carcinoma. Oral Oncol 2015;51(3): 287 e 90 .[32]
Agrawal A, Civantos FJ, Brumund KT, Chepeha DB, Hall NC, Carroll WR, et al. [Tc]Tilmanocept accurately detects sentinel lymph nodes and predicts node pathology status in patients with oral squamous cell carcinoma of the head and neck: results of a phase iii multi-institutional trial. Ann Surg Oncol 2015 .[33]
Brouwer OR, Klop WM, Buckle T, Vermeeren L, van den Brekel MW, Balm AJ, et al. Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluo- rescent tracer. Ann Surg Oncol 2012;19(6):1988 e 94.
C. Schilling et al. / European Journal of Cancer 51 (2015) 2777
e
2784
128